[Clinical evaluation of FAR therapy (radiotherapy with 5FU and vitamin A) for laryngeal cancer. II. Rates of control and complications].
D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D011832:Radiation Injuries / Q000453:epidemiology*; D011879:Radiotherapy Dosage; D014801:Vitamin A / Q000627:therapeutic use*
D014801:Vitamin A; D005472:Fluorouracil